Dedicated to our Patients and Changing the Future of Oncology.

Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next-generation cancer therapeutics – antibody drug conjugates, bispecific antibodies and cytokine derivatives. Unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell.

Our technology not only kills the tumor but also elicits immunogenic cell death

Six Product Candidates Advancing in the Clinic and Late-Stage Discovery Programs

Our Pipeline

Sutro Biopharma is working independently and with partners to develop novel cancer therapies, including antibody-drug conjugates, bispecific antibodies and cytokine derivatives targeting immuno-oncology pathways.

Diversity, Equity, Inclusion and Belonging (DEIB)

Our Commitment to Change.

Sutro Biopharma has partnered with California Life Sciences Association (CLSA) to create a more diverse industry to spark solutions for a better healthier world. CLSA members have raised $1M with a goal of sustaining 3-year commitments of $1M annually for Racial & Social Equity Initiative We Commit To Change

Collaborating with Local Community Organizations

Together, we can make a difference

CuriOdyssey

La Casa de Las Madres

St. Anthony’s Padua Dining Room

Homeless Prenatal Program

Peninsula Bridge

Students Rising Above

Korn Ferry

Peninsula Post Acute

Sunshine Gardens Elementary School

Sign Up for Email Alerts